Cas:5949-05-3 (-)-citronellal manufacturer & supplier

We serve Chemical Name:(-)-citronellal CAS:5949-05-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(-)-citronellal

Chemical Name:(-)-citronellal
CAS.NO:5949-05-3
Synonyms:Citronellal;6-Octenal, 3,7-dimethyl-, (3S)-;MFCD00075588;1720790;(3S)-3,7-dimethyloct-6-enal;(3S)-3,7-Dimethyl-6-octenal;(S)-Citronellal;(-)-Citronellal;(S)-(-)-3,7-Dimethyl-6-octenal;(3S)-(-)-Citronellal;EINECS 227-707-9;(−)-Citronellal;(S)-3,7-Dimethyl-6-octenal;(S)-(-)-Citronellal
Molecular Formula:C10H18O
Molecular Weight:154.249
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:208.4±9.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.437
PSA:17.07000
Exact Mass:154.135757
LogP:3.48

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Citronellal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-(-)-Citronellal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00075588 Use and application,Citronellal technical grade,usp/ep/jp grade.


Related News: The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. (-)-citronellal manufacturer We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. (-)-citronellal supplier Health officials said it remained unclear where he had developed the disease. (-)-citronellal vendor The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. (-)-citronellal factory In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.